Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.57 |
| ▸ | ITGAV | P06756 | 2/20 | 0.57 |
| ▸ | MC4R | P32245 | 9/20 | 0.54 |
| ▸ | MC5R | P33032 | 9/20 | 0.54 |
| ▸ | MC3R | P41968 | 9/20 | 0.54 |
| ▸ | MC1R | Q01726 | 9/20 | 0.54 |
| ▸ | CTSG | P08311 | 2/20 | 0.47 |
| ▸ | PLAU | P00749 | 2/20 | 0.43 |
| ▸ | GRB7 | Q14451 | 1/20 | 0.42 |
| ▸ | GRB2 | P62993 | 2/20 | 0.42 |
| ▸ | TSLP | Q969D9 | 1/20 | 0.41 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13649555 | 0.94 | MC4R (0.56) | ITGB3ITGAVMC4RMC5RMC3R | |
| SCHEMBL13649564 | 0.93 | MC4R (0.55) | ITGB3ITGAVMC4RMC5RMC3R | |
| SCHEMBL11929915 | 0.92 | MC4R (0.58) | ITGB3ITGAVMC4RMC5RMC3R | |
| SCHEMBL13703200 | 0.90 | MC4R (0.52) | ITGB3ITGAVMC4RMC5RMC3R | |
| SCHEMBL13703448 | 0.89 | MC4R (0.53) | ITGB3ITGAVMC4RMC5RMC3R | |
| SCHEMBL13703202 | 0.87 | MC4R (0.52) | ITGB3ITGAVMC4RMC5RMC3R | |
| SCHEMBL11929553 | 0.86 | MC4R (0.46) | ITGB3ITGAVMC4RMC5RMC3R | |
| SCHEMBL11928877 | 0.84 | ITGB3 (0.64) | ITGB3ITGAVMC4RMC5RMC3R | |
| SCHEMBL13870347 | 0.84 | ITGB3 (0.63) | ITGB3ITGAVMC4RMC5RMC3R | |
| SCHEMBL9908265 | 0.84 | ITGB3 (0.63) | ITGB3ITGAVMC4RMC5RMC3R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8236283-B2 | Optical imaging | GE HEALTHCARE AS (NO) | 2012-08-07 | — | — | US | disclosed |
| US-20090232741-A1 | Optical Imaging | GE HEALTHCARE AS (NO) | 2009-09-17 | — | — | US | disclosed |
| US-20090232741-A1 | Optical Imaging | GE HEALTHCARE AS (NO) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090232741-A1 | Optical Imaging | AGER, KDR, FLT4 | ITGB3 78/4885ITGAV 49/4885MC4R 244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.